Global Asthma and COPD Devices Market Research Report 2024

Publication ID:

PB505248655

Publication Date:

May 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Asthma is refered to a chronic respiratory disease which blocks the airways of lung because of mucus production, inflammation, and tightening of muscles. Similarly, Chronic Obstructive Pulmonary Disease(COPD) is caused by the blockade in the airways further resulting in difficulty in breathing, owing to the primary cause as tobacco smoking. Asthma and COPD Devices are the Devices which are used to treat these afore-mentioned respiratory diseases.
The global Asthma and COPD Devices market was valued at US$ 29780 million in 2023 and is anticipated to reach US$ 42100 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
North American market for Asthma and COPD Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Asthma and COPD Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Asthma and COPD Devices include AstraZeneca, Boehringer Ingelheim, Drive DeVilbiss Healthcare, GF Health Products, Glaxosmithcline, Invacare, Merck, Omron Healthcare and PARI Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Asthma and COPD Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma and COPD Devices.
Report Scope
The Asthma and COPD Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma and COPD Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma and COPD Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Boehringer Ingelheim
Drive DeVilbiss Healthcare
GF Health Products
Glaxosmithcline
Invacare
Merck
Omron Healthcare
PARI Pharma
Philips Healthcare
Segment by Type
Inhaler
Nebulizer
Segment by Application
Hospital
Online Store
Medical Machinery Sales Center
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma and COPD Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma and COPD Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Asthma and COPD Devices Market Overview
1.1 Product Overview and Scope of Asthma and COPD Devices
1.2 Asthma and COPD Devices Segment by Type
1.2.1 Global Asthma and COPD Devices Market Value Comparison by Type (2024-2030)
1.2.2 Inhaler
1.2.3 Nebulizer
1.3 Asthma and COPD Devices Segment by Application
1.3.1 Global Asthma and COPD Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Online Store
1.3.4 Medical Machinery Sales Center
1.3.5 Other
1.4 Global Asthma and COPD Devices Market Size Estimates and Forecasts
1.4.1 Global Asthma and COPD Devices Revenue 2019-2030
1.4.2 Global Asthma and COPD Devices Sales 2019-2030
1.4.3 Global Asthma and COPD Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma and COPD Devices Market Competition by Manufacturers
2.1 Global Asthma and COPD Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma and COPD Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma and COPD Devices Average Price by Manufacturers (2019-2024)
2.4 Global Asthma and COPD Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma and COPD Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma and COPD Devices, Product Type & Application
2.7 Asthma and COPD Devices Market Competitive Situation and Trends
2.7.1 Asthma and COPD Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma and COPD Devices Players Market Share by Revenue
2.7.3 Global Asthma and COPD Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma and COPD Devices Retrospective Market Scenario by Region
3.1 Global Asthma and COPD Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma and COPD Devices Global Asthma and COPD Devices Sales by Region: 2019-2030
3.2.1 Global Asthma and COPD Devices Sales by Region: 2019-2024
3.2.2 Global Asthma and COPD Devices Sales by Region: 2025-2030
3.3 Global Asthma and COPD Devices Global Asthma and COPD Devices Revenue by Region: 2019-2030
3.3.1 Global Asthma and COPD Devices Revenue by Region: 2019-2024
3.3.2 Global Asthma and COPD Devices Revenue by Region: 2025-2030
3.4 North America Asthma and COPD Devices Market Facts & Figures by Country
3.4.1 North America Asthma and COPD Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma and COPD Devices Sales by Country (2019-2030)
3.4.3 North America Asthma and COPD Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma and COPD Devices Market Facts & Figures by Country
3.5.1 Europe Asthma and COPD Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma and COPD Devices Sales by Country (2019-2030)
3.5.3 Europe Asthma and COPD Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma and COPD Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma and COPD Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma and COPD Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma and COPD Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma and COPD Devices Market Facts & Figures by Country
3.7.1 Latin America Asthma and COPD Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma and COPD Devices Sales by Country (2019-2030)
3.7.3 Latin America Asthma and COPD Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma and COPD Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma and COPD Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma and COPD Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma and COPD Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma and COPD Devices Sales by Type (2019-2030)
4.1.1 Global Asthma and COPD Devices Sales by Type (2019-2024)
4.1.2 Global Asthma and COPD Devices Sales by Type (2025-2030)
4.1.3 Global Asthma and COPD Devices Sales Market Share by Type (2019-2030)
4.2 Global Asthma and COPD Devices Revenue by Type (2019-2030)
4.2.1 Global Asthma and COPD Devices Revenue by Type (2019-2024)
4.2.2 Global Asthma and COPD Devices Revenue by Type (2025-2030)
4.2.3 Global Asthma and COPD Devices Revenue Market Share by Type (2019-2030)
4.3 Global Asthma and COPD Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma and COPD Devices Sales by Application (2019-2030)
5.1.1 Global Asthma and COPD Devices Sales by Application (2019-2024)
5.1.2 Global Asthma and COPD Devices Sales by Application (2025-2030)
5.1.3 Global Asthma and COPD Devices Sales Market Share by Application (2019-2030)
5.2 Global Asthma and COPD Devices Revenue by Application (2019-2030)
5.2.1 Global Asthma and COPD Devices Revenue by Application (2019-2024)
5.2.2 Global Asthma and COPD Devices Revenue by Application (2025-2030)
5.2.3 Global Asthma and COPD Devices Revenue Market Share by Application (2019-2030)
5.3 Global Asthma and COPD Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Asthma and COPD Devices Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Asthma and COPD Devices Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Drive DeVilbiss Healthcare
6.3.1 Drive DeVilbiss Healthcare Corporation Information
6.3.2 Drive DeVilbiss Healthcare Description and Business Overview
6.3.3 Drive DeVilbiss Healthcare Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Drive DeVilbiss Healthcare Asthma and COPD Devices Product Portfolio
6.3.5 Drive DeVilbiss Healthcare Recent Developments/Updates
6.4 GF Health Products
6.4.1 GF Health Products Corporation Information
6.4.2 GF Health Products Description and Business Overview
6.4.3 GF Health Products Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GF Health Products Asthma and COPD Devices Product Portfolio
6.4.5 GF Health Products Recent Developments/Updates
6.5 Glaxosmithcline
6.5.1 Glaxosmithcline Corporation Information
6.5.2 Glaxosmithcline Description and Business Overview
6.5.3 Glaxosmithcline Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Glaxosmithcline Asthma and COPD Devices Product Portfolio
6.5.5 Glaxosmithcline Recent Developments/Updates
6.6 Invacare
6.6.1 Invacare Corporation Information
6.6.2 Invacare Description and Business Overview
6.6.3 Invacare Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Invacare Asthma and COPD Devices Product Portfolio
6.6.5 Invacare Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Asthma and COPD Devices Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Omron Healthcare
6.8.1 Omron Healthcare Corporation Information
6.8.2 Omron Healthcare Description and Business Overview
6.8.3 Omron Healthcare Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Omron Healthcare Asthma and COPD Devices Product Portfolio
6.8.5 Omron Healthcare Recent Developments/Updates
6.9 PARI Pharma
6.9.1 PARI Pharma Corporation Information
6.9.2 PARI Pharma Description and Business Overview
6.9.3 PARI Pharma Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PARI Pharma Asthma and COPD Devices Product Portfolio
6.9.5 PARI Pharma Recent Developments/Updates
6.10 Philips Healthcare
6.10.1 Philips Healthcare Corporation Information
6.10.2 Philips Healthcare Description and Business Overview
6.10.3 Philips Healthcare Asthma and COPD Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Philips Healthcare Asthma and COPD Devices Product Portfolio
6.10.5 Philips Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma and COPD Devices Industry Chain Analysis
7.2 Asthma and COPD Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma and COPD Devices Production Mode & Process
7.4 Asthma and COPD Devices Sales and Marketing
7.4.1 Asthma and COPD Devices Sales Channels
7.4.2 Asthma and COPD Devices Distributors
7.5 Asthma and COPD Devices Customers
8 Asthma and COPD Devices Market Dynamics
8.1 Asthma and COPD Devices Industry Trends
8.2 Asthma and COPD Devices Market Drivers
8.3 Asthma and COPD Devices Market Challenges
8.4 Asthma and COPD Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AstraZeneca
Boehringer Ingelheim
Drive DeVilbiss Healthcare
GF Health Products
Glaxosmithcline
Invacare
Merck
Omron Healthcare
PARI Pharma
Philips Healthcare

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂